Precigen Inc

NASDAQ: PGEN
$0.98
+$0.02 (+2.6%)
Closing Price on November 8, 2024

PGEN Stock Chart and Intraday Price

PGEN Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector TRADE & SERVICES
Industry SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Address 1750 KRAFT DRIVE, SUITE 1400, BLACKSBURG, VA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 420.67M USD
Shares Outstanding 248,919,000
Precigen, Inc., originally known as Intrexon Corporation, is a biopharmaceutical company based in Germantown, Maryland, focusing on developing gene and cell therapies. With a foundation laid in 1998, Precigen advances treatments for a variety of diseases, including those in immuno-oncology, autoimmune disorders, and infectious diseases. The company's innovative precision technology propels its pipeline of preclinical and clinical therapies towards commercialization, aiming to revolutionize biotherapeutic solutions.

PGEN Articles

Are you interested in investing in penny stocks? Though doing so does come with risk, making the right investment decisions in the penny stock category can produce eye-opening returns. While the...
A beneficial owner made a huge buy of shares in a trucking company this past week. That was not the only big insider buying though.